tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Financial Statements

Compare
2 Followers

Everest Medicines Ltd. Financial Overview

Everest Medicines Ltd.'s market cap is currently HK$15.58B. The company's EPS TTM is HK$-3.504; its P/E ratio is ―; Everest Medicines Ltd. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 706.68M¥ 125.93M¥ 12.79M¥ 54.00K¥ 0.00
Gross Profit¥ 528.89M¥ 91.52M¥ 8.15M¥ 31.00K¥ 0.00
Operating Income¥ -1.12B¥ -932.74M¥ -1.40B¥ -1.05B¥ -688.46M
EBITDA¥ -670.04M¥ -744.63M¥ -198.91M¥ -972.78M¥ -683.03M
Net Income¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.68B
Balance Sheet
Cash & Short-Term Investments¥ 1.60B¥ 2.35B¥ 1.65B¥ 2.64B¥ 4.48B
Total Assets¥ 4.96B¥ 5.77B¥ 6.61B¥ 6.65B¥ 7.48B
Total Debt¥ 575.61M¥ 510.63M¥ 503.71M¥ 485.03M¥ 447.33M
Net Debt¥ -308.86M¥ -12.44M¥ 12.93M¥ -2.16B¥ -4.03B
Total Liabilities¥ 886.05M¥ 804.10M¥ 960.25M¥ 753.83M¥ 636.11M
Stockholders' Equity¥ 4.07B¥ 4.97B¥ 5.65B¥ 5.89B¥ 6.84B
Cash Flow
Free Cash Flow¥ -744.92M¥ -1.04B¥ -1.59B¥ -1.71B¥ -991.83M
Operating Cash Flow¥ -679.51M¥ -769.19M¥ -1.16B¥ -729.94M¥ -471.90M
Investing Cash Flow¥ 974.40M¥ 752.50M¥ -1.03B¥ -975.82M¥ -519.93M
Financing Cash Flow¥ 37.80M¥ 10.10M¥ -25.31M¥ -76.51M¥ 5.64B
Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History

Everest Medicines Ltd. Debt to Assets

Everest Medicines Ltd. Cash Flow

Everest Medicines Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis